Edition:
United Kingdom

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

23.48CAD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$23.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,140,447
52-wk High
$30.56
52-wk Low
$11.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.68 December 21 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 8 10 10 12
(4) UNDERPERFORM 6 5 5 5
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 2.95 2.95 2.95

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 8 2,012.47 2,215.00 1,868.50 2,092.20
Quarter Ending Jun-18 8 2,114.92 2,240.00 1,999.70 2,116.80
Year Ending Dec-18 19 8,423.88 9,160.00 7,956.00 9,211.78
Earnings (per share)
Quarter Ending Mar-18 7 0.68 0.90 0.46 1.00
Quarter Ending Jun-18 7 0.84 0.90 0.73 1.04
Year Ending Dec-18 17 3.49 4.57 2.96 5.52
LT Growth Rate (%) 2 -7.75 -2.00 -13.50 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 2,157.55 2,219.00 61.45 2.85
Quarter Ending Jun-17 2,218.52 2,233.00 14.48 0.65
Quarter Ending Mar-17 2,183.75 2,109.00 74.75 3.42
Quarter Ending Dec-16 2,338.27 2,403.00 64.73 2.77
Quarter Ending Sep-16 2,494.01 2,479.60 14.41 0.58
Earnings (per share)
Quarter Ending Sep-17 0.89 1.04 0.15 16.60
Quarter Ending Jun-17 0.94 1.03 0.09 9.09
Quarter Ending Mar-17 0.87 0.78 0.09 9.99
Quarter Ending Dec-16 1.20 1.26 0.06 4.59
Quarter Ending Sep-16 1.75 1.55 0.20 11.42

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2,012.47 2,012.47 2,026.53 2,036.97 2,092.20
Quarter Ending Jun-18 2,114.92 2,114.92 2,122.41 2,123.09 2,116.80
Year Ending Dec-18 8,423.88 8,423.88 8,426.64 8,465.64 9,211.78
Earnings (per share)
Quarter Ending Mar-18 0.68 0.68 0.70 0.66 1.00
Quarter Ending Jun-18 0.84 0.84 0.84 0.83 1.04
Year Ending Dec-18 3.49 3.49 3.51 3.56 5.52

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 2 2
Quarter Ending Jun-18 0 0 2 2
Year Ending Dec-18 0 0 2 3
Earnings
Quarter Ending Mar-18 0 0 1 3
Quarter Ending Jun-18 0 0 2 2
Year Ending Dec-18 0 0 2 3